These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6183699)

  • 41. Controlled-release interferon alpha 2b, a new member of the interferon family for the treatment of chronic hepatitis C.
    Jansen PL; De Bruijne J
    Expert Opin Investig Drugs; 2012 Jan; 21(1):111-8. PubMed ID: 22126968
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human fibroblast interferon in human neoplasia: clinical and laboratory study.
    Horoszewicz JS; Leong SS; Ito M; Buffett RF; Karakousis C; Holyoke E; Job L; Dölen JG; Carter WA
    Cancer Treat Rep; 1978 Nov; 62(11):1899-906. PubMed ID: 728909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protective effect of different mouse interferons in mice infected with encephalomyocarditis (EMC).
    Lobodzińska M; Albin M
    Arch Immunol Ther Exp (Warsz); 1982; 30(1-2):49-55. PubMed ID: 6184029
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of cell membrane in the antiviral effect of interferon.
    Pitha PM; Vengris VE; Reynolds FH
    J Supramol Struct; 1976; 4(4):467-73. PubMed ID: 778494
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interferon: a changing picture.
    Larke RP
    Can Med Assoc J; 1966 Jan; 94(1):23-31. PubMed ID: 5322363
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Exogenous interferon in animals and its clinical implications.
    Finter NB
    Arch Intern Med; 1970 Jul; 126(1):147-57. PubMed ID: 4987552
    [No Abstract]   [Full Text] [Related]  

  • 47. Interferons: from molecular biology to man. Part 1. Genetics and molecular biology of the interferon system.
    Balkwill FR
    Microbiol Sci; 1986 Jul; 3(7):212-5. PubMed ID: 2484748
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Some biological activities of rabbit anti-interferon serum.
    Fuchsberger N; Styk B; Borecký L; Hajnická V
    Acta Virol; 1976 Apr; 20(2):107-13. PubMed ID: 5864
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic and pharmacological aspects of interferon therapy in man.
    Billiau A
    Acta Microbiol Acad Sci Hung; 1981; 28(3):257-62. PubMed ID: 6171139
    [No Abstract]   [Full Text] [Related]  

  • 50. [Antiviral activity of interferon and its inducers in human lymphoblastoid and somatic cells].
    Novokhatskiĭ AS; Labzo SS; Tsareva AA
    Antibiotiki; 1979 Apr; 24(4):294-9. PubMed ID: 220908
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes of antipyrine pharmacokinetics during influenza and after administration of interferon-alpha and -beta.
    Brockmeyer NH; Barthel B; Mertins L; Goos M
    Int J Clin Pharmacol Ther; 1998 Jun; 36(6):309-11. PubMed ID: 9660037
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Is interferon tissue specific?- Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines.
    Einhorn S; Strander H
    J Gen Virol; 1977 Jun; 35(3):573-7. PubMed ID: 267737
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacokinetics of interferons. A reappraisal.
    Bocci V
    Tex Rep Biol Med; 1981-1982; 41():336-43. PubMed ID: 6184823
    [No Abstract]   [Full Text] [Related]  

  • 54. Characterization of antiviral activity of spotted souslik (Spermophilus suslicus) interferons.
    Kandefer-Szerszeń M
    Arch Immunol Ther Exp (Warsz); 1987; 35(4):489-99. PubMed ID: 2449874
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Comparative study of the biological properties of plasmid and natural human interferons].
    Ovchinnikov IuA; Zhdanov VM; Solov'ev VD; Novokhatskiĭ AS; Aspetov RD
    Vopr Virusol; 1983; 28(1):14-21. PubMed ID: 6189294
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The role of liver in the catabolism of human alpha- and beta-interferon.
    Bocci V; Pacini A; Bandinelli L; Pessina GP; Muscettola M; Paulesu L
    J Gen Virol; 1982 Jun; 60(Pt 2):397-400. PubMed ID: 6180128
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacology and side-effects of interferons.
    Bocci V
    Antiviral Res; 1994 Jul; 24(2-3):111-9. PubMed ID: 7526785
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The present status of clinical studies with interferons in cancer in Britain.
    Priestman TJ
    Philos Trans R Soc Lond B Biol Sci; 1982 Sep; 299(1094):119-24. PubMed ID: 6183686
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Renal metabolism of homologous serum interferon.
    Bocci V; Di Francesco P; Pacini A; Pessina GP; Rossi GB; Sorrentino V
    Antiviral Res; 1983 Mar; 3(1):53-8. PubMed ID: 6191655
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Interferon therapy: pharmacokinetic and pharmacological aspects.
    Billiau A
    Arch Virol; 1981; 67(2):121-33. PubMed ID: 6163417
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.